Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
CC transcript
Appointed director

Ocera Therapeutics, Inc. (OCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 0% stake in Ocera Therapeutics, Inc.
12/21/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/14/2017 SC 13D/A Domain Partners VIII, L.P. reports a 0% stake in Ocera Therapeutics, Inc.
12/14/2017 EFFECT Form EFFECT - Notice of Effectiveness:
12/14/2017 EFFECT Form EFFECT - Notice of Effectiveness:
12/14/2017 EFFECT Form EFFECT - Notice of Effectiveness:
12/13/2017 4 DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 47,963 shares @ $0
12/13/2017 4 DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 15,731 shares @ $0
12/13/2017 4 Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 1,857,036 shares @ $0
Disposed/sold 20,150 options to buy @ $0.67, valued at $13.5k
12/13/2017 4 DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 7,333 shares @ $0
12/13/2017 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 988,285 shares @ $0
12/11/2017 4 Grais Linda S (President and CEO) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 230,000 shares @ $1.52, valued at $349.6k
Disposed/sold 70,000 shares @ $1.52, valued at $106.4k
Disposed/sold 289,200 options to buy @ $2.15, valued at $621.8k
Disposed/sold 348,600 options to buy @ $2.98, valued at $1M
Disposed/sold 160,000 options to buy @ $3.76, valued at $601.6k
Disposed/sold 491,550 options to buy @ $7.38, valued at $3.6M
Disposed/sold 37,500 options to buy @ $7.84, valued at $294k
Disposed/sold 30,826 options to buy @ $0.67, valued at $20.7k
Disposed/sold 30,827 options to buy @ $0.67, valued at $20.7k
Disposed/sold 11,969 options to buy @ $0.67, valued at $8k
12/11/2017 4 Kjellson Nina S (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 12,500 shares @ $1.52, valued at $19k
Disposed/sold 20,000 options to buy @ $7.85, valued at $157k
Disposed/sold 10,000 options to buy @ $7.84, valued at $78.4k
Disposed/sold 10,000 options to buy @ $3.76, valued at $37.6k
Disposed/sold 12,500 options to buy @ $2.26, valued at $28.3k
12/11/2017 4 Bukofzer Stan (Chief Medical Officer) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 2,500 shares @ $1.52, valued at $3.8k
Disposed/sold 200,000 shares @ $1.52, valued at $304k
Disposed/sold 300,000 options to buy @ $3.06, valued at $918k
Disposed/sold 208,350 options to buy @ $2.15, valued at $448k
12/11/2017 4 James Steven P (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 12,500 shares @ $1.52, valued at $19k
Disposed/sold 20,000 options to buy @ $5.51, valued at $110.2k
Disposed/sold 10,000 options to buy @ $3.76, valued at $37.6k
Disposed/sold 12,500 options to buy @ $2.26, valued at $28.3k
12/11/2017 4 Byrnes Michael (CFO and Treasurer) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 13,000 shares @ $1.52, valued at $19.8k
Disposed/sold 150,000 shares @ $1.52, valued at $228k
Disposed/sold 123,300 options to buy @ $2.98, valued at $367.4k
Disposed/sold 55,000 options to buy @ $7.5, valued at $412.5k
Disposed/sold 75,000 options to buy @ $3.76, valued at $282k
Disposed/sold 102,300 options to buy @ $2.15, valued at $219.9k
Disposed/sold 70,000 options to buy @ $7.5, valued at $525k
12/11/2017 4 Dere Willard H (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 12,500 shares @ $1.52, valued at $19k
Disposed/sold 20,000 options to buy @ $2.425, valued at $48.5k
12/11/2017 4 VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 12,500 shares @ $1.52, valued at $19k
Disposed/sold 12,500 options to buy @ $2.26, valued at $28.3k
Disposed/sold 20,000 options to buy @ $7.85, valued at $157k
Disposed/sold 10,000 options to buy @ $3.76, valued at $37.6k
Disposed/sold 2,083 options to buy @ $48, valued at $100k
Disposed/sold 2,652 options to buy @ $50.88, valued at $134.9k
Disposed/sold 10,000 options to buy @ $7.84, valued at $78.4k
12/11/2017 4 WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 344,719 shares @ $1.52, valued at $524k
Disposed/sold 11,969 shares @ $1.52, valued at $18.2k
Disposed/sold 12,500 shares @ $1.52, valued at $19k
Disposed/sold 2,992 options to buy @ $1.84, valued at $5.5k
Disposed/sold 20,000 options to buy @ $7.85, valued at $157k
Disposed/sold 10,000 options to buy @ $7.84, valued at $78.4k
Disposed/sold 10,000 options to buy @ $3.76, valued at $37.6k
Disposed/sold 12,500 options to buy @ $2.26, valued at $28.3k
12/11/2017 4 WIERENGA WENDALL (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Disposed/sold 5,000 shares @ $1.52, valued at $7.6k
Disposed/sold 12,500 shares @ $1.52, valued at $19k
Disposed/sold 20,000 options to buy @ $13.25, valued at $265k
Disposed/sold 10,000 options to buy @ $7.84, valued at $78.4k
Disposed/sold 10,000 options to buy @ $3.76, valued at $37.6k
Disposed/sold 12,500 options to buy @ $2.26, valued at $28.3k
12/11/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/11/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/11/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/11/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/11/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/11/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/11/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/11/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/11/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/11/2017 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of Ocera Therapeutics, Inc",
"Amended and Restated Bylaws of Ocera Therapeutics, Inc"
12/11/2017 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
12/11/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
12/11/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy